Jump Financial, LLC Ventyx Biosciences, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.85 - $3.2 $195,796 - $338,675	-105,836 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$2.31 - $5.59 $244,481 - $591,623	105,836 New	105,836 $244,000
Q4 2023 Oct 21, 2024	SELL	$2.08 - $31.18 $159,694 - $2.39 Million	-76,776 Reduced 72.54%	29,060 $71,000
Q4 2023 Feb 07, 2024	BUY	$2.08 - $31.18 $60,444 - $906,090	29,060 New	29,060 $71,000
Q4 2022 Feb 13, 2023	BUY	$24.16 - $36.38 $847,291 - $1.28 Million	35,070 New	35,070 $1.15 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $128M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.